You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Colombia

Mar 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Colombia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Colombia, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Colombia for free:

The Consumer Health in Colombia market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Colombia?
  • What are the major brands in Colombia?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Decreasing rate of growth of consumer health value sales as generics gain share

Growth in consumer health has not shown the same behaviour as that seen in the beginning of the review period. Value sales growth continues being negatively affected by the increasing importance of generics across consumer health categories, as these products feature lower prices.

Ageing of Colombians, a key healthcare products sales driver

The ageing of the population has become the most important trend as demand for medications depends now more strongly on the older segment of the population. Elders have fuelled sales and have an increasing impact on product development. As Colombians live longer, they want to maintain their physical and mental health in good shape. With age, pain becomes a greater concern amongst Colombians, and this explains why as this segment of the population grew in share, analgesics continued being one of the fastest-growing categories in 2010 and also one of the largest in value sales terms.

GlaxoSmithKline de Colombia continues leading sales of consumer health

GlaxoSmithKline de Colombia remained as the leader in sales in consumer health and it was followed by Laboratorios Wyeth Inc. GlaxoSmithKline was amongst the 20 top-spending companies in publicity in Colombia and that investment has fuelled sales. Dolex increased its share of GlaxoSmithKline’s sales and it had a faster growth than in former years, which was crucial in the overall performance of the company.

Droguerias Cafam expands thanks to its alliance with Almacenes Éxito

A channel that is strengthening is that of parapharmacies/drugstores after Cafam made an alliance with Almacenes Éxito, the largest Colombian retailer in 2009. It gives Cafam’s drugstores the possibility of changing the fascia of all pharmacies inside Éxito’s hypermarkets to that of Cafam. Given the long experience this company has operating this type of channel, it is expected that sales of consumer health products will strengthen through this alliance.

Need of new products to drive growth in forecast period

Although the constant value growth rate over the forecast period is expected to be a little bit slower than it was during the review period, there are still plenty of opportunities in consumer health in Colombia. For example, the development of probiotics in packaged food could create demand in a new category. The positive press coverage of probiotics internationally is likely to help its development within the country. Probiotics’ benefits are expected to be publicised in Colombia by pharmaceutical companies present in consumer health.

Table of Contents

Table of Contents

Consumer Health in Colombia - Industry Overview

EXECUTIVE SUMMARY

Decreasing rate of growth of consumer health value sales as generics gain share

Ageing of Colombians, a key healthcare products sales driver

GlaxoSmithKline de Colombia continues leading sales of consumer health

Droguerias Cafam expands thanks to its alliance with Almacenes Éxito

Need of new products to drive growth in forecast period

KEY TRENDS AND DEVELOPMENTS

Pseudoephedrine- and ephedrine-based medications banned in 2010

Pain remains a main concern for Colombians

Ageing of the population

Generics continue being successfully produced and sold by domestic laboratories

Self-medication remains an extensive practice in Colombia

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Penetration of Private Label by Category 2005-2010
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC registration and classification

Delisting or de-reimbursement

Advertising

Packaging and Labelling

Distribution

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

DEFINITIONS

  • Summary 1 Research Sources

Consumer Health in Colombia - Company Profiles

Biochem Farmaceútica de Colombia SA - Consumer Health - Colombia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 4 Biochem Farmacéutica de Colombia SA: Production Statistics 2009

COMPETITIVE POSITIONING

  • Summary 5 Biochem Farmacéutica de Colombia SA: Competitive Position 2010

Laboratorios Natural Freshly Infabo Ltda - Consumer Health - Colombia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Laboratorios Natural Freshly Infabo Ltda: Competitive Position 2010

Lafrancol SA - Consumer Health - Colombia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 11 Lafrancol SA: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 12 Lafrancol SA: Competitive Position 2010

Omnilife Manufactura de Colombia Ltda - Consumer Health - Colombia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 15 Omnilife Manufactura de Colombia Ltda: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 16 Omnilife Manufactura de Colombia Ltda: Competitive Position 2010

Tecnoquímicas SA - Consumer Health - Colombia

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 19 Tecnoquímicas SA: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 20 Summary Tecnoquímicas SA: Competitive Position 2010

Adult Mouth Care in Colombia - Category Analysis

HEADLINES

TRENDS

  • In 2010 value sales of adult mouth care products in Colombia increased by 3% compared to 2009. The increase was a consequence of the improvement in the general income, but it was relatively low as adult mouth care faced the competition from mouthwashes/dental rinses in beauty and personal care as people attribute the same properties to both products. Mouthwashes/dental rinses continues offering a broader set of alternatives that are more widely available than mouth care products through grocers. Adult mouth care is also not widely advertised, making it hard for people to be aware of these products.

SWITCHES

COMPETITIVE LANDSCAPE

  • The company that leads sales is Farpag as two of its brands continue being leaders in the category. Both Dolni K and Clorhexol have continued being amongst the brands with highest value sales, helped both by prices that have been steadily increased and by the company’s marketing efforts directed to dentists.

PROSPECTS

  • In the forecast period, adult mouth care is expected to stagnate unless a more aggressive approach is undertaken by the leading companies. They could direct their efforts more directly to customers and order to fuel sales thanks to a greater recognition.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2005-2010
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 14 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 15 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in Colombia - Category Analysis

HEADLINES

TRENDS

  • There were important launches in analgesics as GlaxoSmithKline de Colombia offered new versions of Dolex. It shows how acetaminophen products are still the first choice for consumers when looking for a pain reliever. This is true despite the new launches in other types of analgesics such as ibuprofen products. Advil was especially active in new launches in ibuprofen but the category remained way behind acetaminophen and aspirin in sales. One of the reasons can be that ibuprofen products are still perceived as more potentially dangerous as ibuprofen can negatively affect the kidneys.

SWITCHES

COMPETITIVE LANDSCAPE

  • The leading company is GlaxoSmithKline de Colombia with Dolex remaining its star product and the best-selling analgesic in the country. It is followed by Bayer, which despite some slight reduction in share is still very important. The third company is Tecnoquímicas, which has been able to position itself as a high-quality generics company as has been acknowledged by some physicians and chemists who were interviewed.

PROSPECTS

  • Analgesics is expected to show a constant value CAGR close to 4% in the forecast period. It will be fuelled by what seems an increase in awareness around pain-related problems as pain is one of the most common problems that negatively affect Colombians and consumers are becoming more comfortable using analgesics. Also, since pain is considered a problem that in general can be fought through self-medication, this will play an important role in OTC analgesics demand.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2005-2010
  • Table 19 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 21 Analgesics Company Shares by Value 2006-2010
  • Table 22 Analgesics Brand Shares by Value 2007-2010
  • Table 23 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in Colombia - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping products are mostly natural, as there is a strict control over such products. Anxiolytics and standard medications aimed at controlling the quality of sleep can present problems such as dependency from those substances, which is a risk that is not associated to herbal and traditional remedies such as valerian and passiflora. Also, the ingredients in herbal products are usually known by tradition, which makes it easier for people to understand the benefits they offer.

SWITCHES

COMPETITIVE LANDSCAPE

  • Labfarve leads the category as this has been one of the main companies making herbal/traditional products, and it has been able to position itself strongly as it has a wide presence through the different channels. Also, Labfarve is backed by a medical school and that has also helped its sales as it has strengthened its brands. Lafrancol ranks second and its investment in television campaigns can be a reason for its success.

PROSPECTS

  • A close to 5% constant value CAGR growth is expected in the forecast period for calming and sleeping products, which will be mainly driven by branded products such as the current leader Labfarve and Lafrancol, due to the recognition these brands have, which makes them more reliable to consumers. This will influence higher consumer awareness about the products, and increasingly stressful and hectic lifestyles will impact the products’ acceptance and trial uses. Rx products are expected to improve their performance, which could increase the acceptance of synthetic products, as publications about them show how they are the result of increasing scientific knowledge of the human body and therefore their effectiveness is higher than that of other products.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2005-2010
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 27 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 28 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in Colombia - Category Analysis

HEADLINES

TRENDS

  • As ingredients such as pseudoephedrine were used to make some cold remedies but also as raw materials for some illegal drugs, as is the case of amphetamines, the Colombian government decided to withdraw it in May 2010. After this prohibition, although there is no evidence of it, there is the possibility that some pseudoephedrine-based products were sold UTC in some pharmacies or drugstores.

COMPETITIVE LANDSCAPE

  • The category is led by such brands as Halls from Cadbury Columbia SA and Dristan from Laboratorios Wyeth Inc. Halls is a product that was widely advertised throughout the review period and it is a confectionery product that has an extensive use for sore throat. Since it has no contraindications, it falls in the blurry line between a candy and a medication.

PROSPECTS

  • Since price will continue being a critical variable, companies are expected to work in the direction of increasingly featuring less expensive products. Companies offering cough, cold and allergy remedies should work in that direction. As new variations of respiratory diseases appear, it will gain importance the use of cough, cold and allergy medications that will attack effectively those illnesses. But at the same time a possible outcome would be that during the forecast period, some medications belonging to this category could become Rx as their active ingredients could become stronger and hence their use should only be prescribed by physicians.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 33 Sales of Decongestants by Category: Value 2005-2010
  • Table 34 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 36 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in Colombia - Category Analysis

HEADLINES

TRENDS

  • Some products that were until 2009 non-OTC were unlisted and now do not require a prescription. This is the case of omeprazole-based products, which in some smaller dosages can be freely purchased, as occurs with its 10mg presentation. Higher doses, including 20mg, continue being sold under prescription in Colombia.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer de Colombia SA remains as the main company in the digestive remedies category as Alka Seltzer continues being a highly demanded product for all types of digestive problems. Although the brand is slowly losing share, its actual value sales increased in 2010.

PROSPECTS

  • It is expected that digestive remedies will have a moderate growth of 6% in constant value terms over the forecast period. The government is increasingly concerned about the nutrition of Colombians and it is expected that in the forecast period there will be campaigns that will be effective in reducing bad nutrition habits. This will play against digestive remedies’ sales, but at the same time some other variables such as the increasingly stressful lifestyles will increase heartburn and other gastric problems amongst Colombians and limit sales decrease.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 43 Digestive Remedies Company Shares by Value 2006-2010
  • Table 44 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in Colombia - Category Analysis

HEADLINES

TRENDS

  • Ear care accounted for sales of Col$260 million in 2009. This category continued showing slow growth as prescriptions continue being the driver of purchases; ears are considered very delicate organs and people prefer to visit a doctor in case of any ear problem. Also, there is a higher incidence of ear problems in children, and it is more common for parents to take children to a doctor. The category lacks dynamism, as there are no mass advertising campaigns to position the brands.

SWITCHES

COMPETITIVE LANDSCAPE

  • Value sales of ear care are basically shared by two companies. The first company in 2010 was the Colombian firm Laboratorios Bussié SA, which accounted for a 53% share of value sales in 2010 with the Oticaina brand, and Laboratorios Wyeth (owned by Pfizer) held a 45% share with the Auralyt Gotas brand, with virtually no competition from other brands. The strongest company growth in 2010 continued being that of Bussié, as it persisted in more aggressive marketing amongst doctors than its competition.

PROSPECTS

  • The expected CAGR for the category in the forecast period is close to 2% in constant value terms, which is higher than the CAGR of 0.5% observed in the review period. Consumers are expected to remain reluctant to self-medicate, as children between two and five years old are expected to remain the most affected age group by ear infections. Growth in the forecast period might be threatened by new switches from OTC to Rx for some ear care medications.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2005-2010
  • Table 48 Sales of Ear Care: % Value Growth 2005-2010
  • Table 49 Ear Care Company Shares by Value 2006-2010
  • Table 50 Ear Care Brand Shares by Value 2007-2010
  • Table 51 Forecast Sales of Ear Care: Value 2010-2015
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2010-2015

Eye Care in Colombia - Category Analysis

HEADLINES

TRENDS

  • In year 2010 sales of eye care accounted for current value sales of Col$2 billion. As pollution in Bogotá is one of the highest in Latin America and people are exposed to excessive sun or wind due to severe changes in weather conditions, and other cities of Colombia are seeing the same problem, eye irritation is a problem that affects many Colombians. As almost 77% of households in Colombia are located in urban areas, there is potential for eye care products in Colombia to grow, and this trend will maintain the demand for this type of products.

SWITCHES

COMPETITIVE LANDSCAPE

  • As in 2009 and the years before, eye care is characterised by a highly fragmented competitive landscape. When looking at the outstanding companies of the category, Laboratorios Alcon de Colombia SA is the leader with a 15% value share in 2010, and this is the company that grew the most. Its brand Tears Naturale is the most important product in OTC eye care products; the brand that followed (Lacril by Allergan Colombia SA) is a brand of artificial tears. It shows the popularity of these products to treat red and dry eyes in Colombia.

PROSPECTS

  • A slightly higher than 2% constant value CAGR is expected in the forecast period. It is expected that the abovementioned causes for red and dry eyes will remain, and that will continue being an important factor that will affect the sales of these products.

CATEGORY DATA

  • Table 53 Sales of Eye Care by Category: Value 2005-2010
  • Table 54 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 55 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 56 Eye Care Company Shares by Value 2006-2010
  • Table 57 Eye Care Brand Shares by Value 2007-2010
  • Table 58 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 59 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in Colombia - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional remedies continue growing their sales in Colombia as their offerings continue increasing and more people are acknowledging their positive effects on human health, as standard medications are associated by some with synthetic substances that may be harmful for people. Some ideas regarding the benefits of natural products are being widely promoted through some media and new technologies such as the internet. Also, the growing use of alternative medicines, as they favour the idea of using more natural products, generates sales.

COMPETITIVE LANDSCAPE

  • The company that led sales remained Cadbury Colombia SA with Col$47 billion sales in 2010 mainly with its Halls brand, whose use is extensive and which is available even through street vendors. This is a product that is highly publicised, and this has been a factor that has helped its sales.

PROSPECTS

  • A CAGR in the forecast period of 3% is expected in constant value terms, and according to some players in the category, there is room for further growth. The big number of medicinal plants that are available in Colombia amounts to about 8,000 according to trade interviews. And the government has only approved about 126. As soon as some decrees that restrict the use of more plants are modified, as is Labfarve’s expectations, new products will be available in Colombia, and that will clearly fuel the growth of this category.

CATEGORY DATA

  • Table 60 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 61 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 62 Herbal/Traditional Products Company Shares 2006-2010
  • Table 63 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 64 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 65 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in Colombia - Category Analysis

HEADLINES

TRENDS

  • In Colombia not only women but also men are increasingly concerned about their skin not only for health concerns but also because they value their looks. It has fuelled the growth of this category, which in 2010 had a value sales increase of 6%. Even the economic crisis has benefited the sales in the sense that as an interviewee mentioned, people think that a better personal appearance will improve their self-confidence and boost some areas of their lives such as the professional. As the trade press mentions, people expect that having a better appearance will improve their chances of getting a job as this becomes a very important issue in times of rising unemployment.

SWITCHES

COMPETITIVE LANDSCAPE

  • Boehringer Ingelheim continued as the leader in the category as it continued investing in advertisements and making campaigns in the community as part of its corporate social responsibility programs. Its topical antiseptic Isodine is its main product in the medicated skin care category.

PROSPECTS

  • It is expected that medicated skin care will have a close to 3% CAGR in constant value terms during the forecast period, as the economy is expected to improve in this period, and the positive attitude towards beauty and wellbeing is expected to continue. Increasing offerings of new products are also expected that will cover new segments such as older men, which will impact sales favourably.

CATEGORY DATA

  • Table 66 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 67 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 68 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 69 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 70 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 71 Acne Treatments Brand Shares by Value 2007-2010
  • Table 72 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 73 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 74 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in Colombia - Category Analysis

HEADLINES

TRENDS

  • After the enactment of an antitobacco law in May 2008, which does not allow smoking in closed spaces such as offices, restaurants and bars, there was an additional motivation for smokers to search for ways that could help them quit smoking. This fuelled NRT smoking cessation aids sales, giving those products an outstanding performance. In the years since 2008, the growth has slowed down after some of those products’ users started to worry about continuing the nicotine dependency and therefore are relying more on their willpower.

SWITCHES

COMPETITIVE LANDSCAPE

  • Pharmacia & Upjohn Colombia with its Nicorette brand continued to lead NRT smoking cessation aids in 2010, with more than 87% value share. Its brand Nicorette was virtually the only brand in Colombia until 2006. The following company was GlaxoSmithKline de Colombia with value share of 8%.

PROSPECTS

  • The CAGR in the forecast period is expected to be around 4% in constant value terms. It is expected to be higher than that of the review period as the expectations are that new products are to be developed in the forecast period showing no risk of addiction, unlike current NRT smoking cessation aids as they contain small doses of nicotine that might still create addiction. In this case, it would equal changing one addiction for another one and this seems a far from perfect solution.

CATEGORY INDICATORS

  • Table 75 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 76 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 77 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 78 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 79 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 80 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 81 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 82 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in Colombia - Category Analysis

HEADLINES

TRENDS

  • After the economic crisis there was some recovery affecting the category of sports nutrition. Also, these products have high prices and they must be consumed along with exercise, which makes them in some ways inconvenient alternatives, a fact that limits their growth. Despite those factors, positive growth has been fuelled by the growing interest amongst men to have well-defined muscular bodies, which makes this a category that had in 2010 a strong gender bias. Also, key competitors such as Amway, UPN Health & Fitness and Omnilife remain very active, using direct marketing strategies through gyms, sponsoring sports events and promoting their products using famous athletes, which has contributed to a stronger positioning for their brands.

COMPETITIVE LANDSCAPE

  • The leading company is UPN Health & Fitness, which had a slightly higher than 46% value share with its brands Megaplex and Megawhey representing more than 32% of total value sales. They are traditional brands that are recommended by sports trainers who consider them effective and having fast action. UPN Health & Fitness is followed by Amway, which had a close to 20% sales value share. This brand has been aggressively promoted by Amway’s independent distributors, who have also been able to attract some sport trainers and gyms as their distributors.

PROSPECTS

  • Growth is expected to be at a 5% constant value CAGR, reaching sales of Col$22 billion in 2015.

CATEGORY DATA

  • Summary 21 Protein ready to drink
  • Table 83 Sales of Sports Nutrition: Value 2005-2010
  • Table 84 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 85 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 86 Sports Nutrition Company Shares 2006-2010
  • Table 87 Sports Nutrition Brand Shares 2007-2010
  • Table 88 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 89 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in Colombia - Category Analysis

HEADLINES

TRENDS

  • Companies were very active in 2010 in doing campaigns favouring better nutrition as was the case of Pfizer, which started a campaign called “Nutrición contigo” (Nutrition with you) to encourage the improvement in the nutrition of kids aged between zero and five years. This group gives advice, has a Facebook group and gives parents access to direct contact with health professionals who answer questions they might have regarding these issues. Some institutions launched similar campaigns, as was the case of Clínica El Bosque in Bogotá, which announced similar efforts, although this time from a health institution, to prevent anaemia in infants younger than two years. This campaign was mainly directed to clinics and health professionals.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Omnilife Manufactura de Colombia Ltda became the new leader in vitamins and dietary supplements in 2010 with 24% value share. Laboratorios Wyeth however still saw an increase of share and also reached 24% in value terms. Wyeth maintains its strong positioning in multivitamins with Centrum, Z-bec and Posture D, and leads calcium supplements with Caltrate and child-specific vitamins such as Centrum Junior, which gives this company a favourable position in vitamins and dietary supplements overall. The company maintains its strategy of using traditional trade channels with mass advertising campaigns and direct marketing to doctors. Omnilife leads multivitamins with Omniplus and tonics and bottled nutritive drinks with Aloe Beta, competing through the direct selling distribution system.

PROSPECTS

  • There is ample space for growth, especially in the case of lower-income segments of the population. There is not a consumption culture of vitamins and dietary supplements amongst them, which is also enforced by the fact that their income makes these products unreachable for them. If stronger actions are taken in terms of promotion and advertising the expected forecast growth would be higher as they represent a large share of the total Colombian population. If players maintain the current target of higher-income segments, the expectation of growth should remain low as those segments are close to saturation because they have been consuming these products for many years.

CATEGORY DATA

  • Table 90 Summary1 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 91 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 92 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 93 Dietary Supplements by Positioning 2005-2010
  • Table 94 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 95 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 96 Vitamins Brand Shares by Value 2007-2010
  • Table 97 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 98 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 99 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in Colombia - Category Analysis

HEADLINES

TRENDS

  • Whilst Colombians continue to be increasingly concerned about body shape, appearance and weight control, obesity has become a public health issue in Colombia and the government is taking action to control it. In 2010, 15.6% of the Colombian population was deemed obese, versus 13.7% in 2005. In 2009, a bill was approved by the Colombian Congress to limit consumption of food and beverages with high caloric content in schools, as obesity amongst children increased rapidly over the review period; the bill also encourages sports practice in schools and preventive education to avoid obesity and has made it mandatory for social services to include obesity treatments as part of their insurance coverage.

COMPETITIVE LANDSCAPE

  • DA Comercializadora Ltda is the company that led sales in 2010 as it is a company that has been able to attract large numbers of people to be its sales representatives. The crisis benefited this company as it was able to attract people who strengthened its sales force and they remained being part of the company as the recovery began in 2010. It is also true that the company has been able to strengthen its positioning as its sales force is well trained and motivated and the company has been able to advertise effectively its products in Colombia through its website.

PROSPECTS

  • The expectations are that in the forecast period there will be more a moderate growth than that of the review period. Alternative products are expected to continue being a challenge to this category as they continue and develop and new choices appear. On the other hand, the idea that beautiful does not mean extra thin will discourage some people from trying to reduce their weight and encourage them to continue looking for other ways that are more directly related to wellbeing than to weight reduction. More exercise, yoga and other techniques could be attracting more people and that could harm weight management demand, and therefore these techniques are to be watched by manufacturers as potential threats for their products.

CATEGORY DATA

  • Table 100 Sales of Weight Management: Value 2005-2010
  • Table 101 Sales of Weight Management: % Value Growth 2005-2010
  • Table 102 Weight Management Company Shares 2006-2010
  • Table 103 Weight Management Brand Shares 2007-2010
  • Table 104 Forecast Sales of Weight Management: Value 2010-2015
  • Table 105 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in Colombia - Category Analysis

HEADLINES

TRENDS

  • Wound care products increased by 6% in 2010, reaching almost Col$14 billion as local companies’ products continued experiencing growth whilst global companies continued investing heavily in marketing. This category has high household penetration, due to the importance of having sticking plasters and other wound treatments in the first aid cabinet in every home, which empowers market dynamics. Players are usually active in this category with promotions, new packaging and sticking plasters with Disney designs (3M Colombia SA, Johnson & Johnson de Colombia SA) which attract children.

COMPETITIVE LANDSCAPE

  • Beiersdorf Colombia SA continued being the leader with a 40% value share and its brands Leucofix and Hansaplast. The company has been in Colombia for many years and it has been able to establish its brands.

PROSPECTS

  • Wound care is expected to grow at a CAGR of 2%. It is just below the 2.2% CAGR from the review period as wound care is a mature category. But wound care still might see some innovation as new effective and more aesthetically appealing products could be offered to consumers, and that would maintain growth in the category.

CATEGORY DATA

  • Table 106 Sales of Wound Care by Category: Value 2005-2010
  • Table 107 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 108 Wound Care Company Shares by Value 2006-2010
  • Table 109 Wound Care Brand Shares by Value 2007-2010
  • Table 110 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 111 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Isoflavones
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
        • Tonics and Bottled Nutritive Drinks
        • Vitamins
          • Multivitamins
          • Single Vitamins
            • Vitamin A
            • Vitamin B
            • Vitamin C
            • Vitamin D
            • Vitamin E
            • Other Single Vitamins
      • Weight Management
        • Meal Replacement Slimming
        • OTC Obesity
        • Slimming Teas
        • Weight Loss Supplements
        • Other Slimming Products
      • Herbal/Traditional Products
        • Herbal/Traditional Analgesics
        • Herbal/Traditional Calming and Sleeping Products
        • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
        • Herbal/Traditional Digestive Remedies
        • Herbal/Traditional Medicated Skin Care
        • Herbal/Traditional Medicinal Teas
        • Herbal/Traditional Smoking Cessation Aids
        • Herbal/Traditional Child-Specific Dietary Supplements
        • Herbal/Traditional Dietary Supplements
        • Herbal/Traditional Tonics and Bottled Nutritive Drinks
      • Allergy Care
        • Allergy Eye Care
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Allergy Remedies
        • Topical Allergy Remedies/Antihistamines
      • Child-Specific Consumer Health
        • Child-Specific Analgesics
          • Child-Specific Acetaminophen
          • Child-Specific Aspirin
          • Child-Specific Combination Products - Analgesics
          • Child-Specific Diclofenac
          • Child-Specific Dipyrone
          • Child-Specific Ibuprofen
          • Child-Specific Ketoprofen
          • Child-Specific Naproxen
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Child-Specific Medicated Skin Care
        • Nappy (Diaper) Rash Treatments
        • Child-Specific Vitamins and Dietary Supplements

    Statistics Included

    Statistics Included

    For each category and subcategory you will receive the following data in Excel format:

    From Passport

    • Market sizes
    • Company shares
    • Brand shares
    • Distribution
    • Analysis by format
    • Analysis by positioning
    • Analysis by type
    • Herbal/traditional vs standard
    • Pricing

    Market size details:

    • Retail volume
    • Retail volume % growth
    • Retail volume per capita
    • Retail value retail selling price % growth
    • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price real (constant 2008) prices % growth
    • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price % growth
    • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price real (constant 2008) prices % growth
    • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price nominal (current) prices % growth
    • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price nominal (current) prices % growth
    • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
    • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

    Methodology

    Methodology

    Global insight and local knowledge

    With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

    This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

    Industry specialists

    Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

    Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

    The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

    Country and regional analysts

    Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

    In-country research network

    To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

    Research Methodology

    Our research methods

    Each Euromonitor International industry report is based on a core set of research techniques:

    Desk research

    With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

    • National statistics offices governmental and official sources
    • National and international trade press
    • National and international trade associations
    • Industry study groups and other semi-official sources
    • Company financials and annual reports
    • Broker reports
    • Online databases
    • The financial, business and mainstream press

    Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

    Store checks

    Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

    • Place: We track products in all relevant channels, selective and mass, store and non-store
    • Product: What are innovations in products, pack sizes and formats?
    • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
    • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

    Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

    Trade survey

    Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

    Trade surveys allow us to:

    • Fill gaps in available published data per company
    • Generate a consensus view of the size, structure and strategic direction of the category
    • Access year-in-progress data where published sources are out of date
    • Evaluate the experts’ views on current trends and market developments

    In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

    Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

    Company analysis

    At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

    At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

    Forecasts

    Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

    Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

    Data validation

    All data is subjected to an exhaustive review process, at country, regional and global levels.

    The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

    Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

    Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

    Market analysis

    Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

    Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

    my pages

    Want to find out more about this report?

    RELATED

    Future Demographic

    Country Report

    Consumer Lifestyle

    Country Report